HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Magilligan, D. J. Articles by Alam, M. Search for Related Content PubMed PubMed Citation Articles by Magilligan, D. J., Jr Articles by Alam, M.

The Annals of Thoracic Surgery, Vol 48, 324-329, Copyright © 1989 by The Society of Thoracic Surgeons

ARTICLES

The porcine bioprosthetic heart valve: experience at 15 years

DJ Magilligan Jr, JW Lewis Jr, P Stein and M Alam
Division of Cardiac and Thoracic Surgery, Henry Ford Hospital, Detroit, Michigan.

The porcine bioprosthetic valve has been in use at Henry Ford Hospital since 1971. In this review, 980 patients with 1,081 porcine bioprosthetic valves were examined from 1 month to 16.4 years after implantation with a 99% complete follow-up. Patient survival was 59% +/- 2.2% (+/- standard error of the mean) at 10 years and 38% +/- 4.0% at 15 years. Factors associated with decreased survival after hospital discharge were age greater than 35 years and New York Heart Association functional class IV. Freedom from thromboembolism was 92% +/- 1.2% at 10 years and 89% +/- 3.2% at 15 years. Freedom from endocarditis was 93% +/- 1.2% at 10 years and 92% +/- 1.3% at 15 years. Freedom from structural valve degeneration for all valves was 71% +/- 2.6% at 10 years and 31% +/- 5.6% at 15 years. Factors associated with increased risk of structural valve degeneration were age younger than 35 years, female sex, and preoperative cardiac index greater than 2 L/min/m2. Among a total of 172 patients undergoing removal of a degenerated valve, mortality was 12.5%, and significant risk factors for death at reoperation were emergency operation and functional class IV. Experience with the porcine bioprosthetic valve after 15 years suggests that its use be confined to older patients or patients with a contraindication of anticoagulation.

This article has been cited by other articles:

				F.-C. Riess, R. Bader, E. Cramer, L. Hansen, B. Kleijnen, G. Wahl, J. Wallrath, S. Winkel, and N. Bleese Hemodynamic Performance of the Medtronic Mosaic Porcine Bioprosthesis Up to Ten Years Ann. Thorac. Surg., April 1, 2007; 83(4): 1310 - 1318. [Abstract] [Full Text] [PDF]

				A. S. Geha, M. G. Massad, and N. J. Snow Replacement of degenerated mitral and aortic bioprostheses without explantation Ann. Thorac. Surg., November 1, 2001; 72(5): 1509 - 1514. [Abstract] [Full Text] [PDF]

				F. Santini, G. B. Luciani, S. Restivo, G. Casali, R. Pessotto, P. Bertolini, A. Rossi, and A. Mazzucco Over twenty-year follow-up of the standard Hancock porcine bioprosthesis implanted in the mitral position Ann. Thorac. Surg., May 1, 2001; 71 (2007): S232 - S235. [Abstract] [Full Text] [PDF]

				Y. Logeais, T. Langanay, A. Leguerrier, C. Rioux, J. Chaperon, and M.-B. Coutte Aortic Carpentier-Edwards supraannular porcine bioprosthesis: a 12-year experience Ann. Thorac. Surg., August 1, 1999; 68(2): 421 - 425. [Abstract] [Full Text] [PDF]

				E. Weinschelbaum, P. Stutzbach, M. Oliva, J. Zaidman, A. Torino, and E. Gabe MANUAL DEBRIDEMENT OF THE AORTIC VALVE IN ELDERLY PATIENTS WITH DEGENERATIVE AORTIC STENOSIS J. Thorac. Cardiovasc. Surg., June 1, 1999; 117(6): 1157 - 1165. [Abstract] [Full Text] [PDF]

				B. Yamak, B. Mavitas, A. Saritas, S F. Katircioglu, A T. Ulus, L. Birincioglu, Y H. Karagoz, E. Sener, O. Tasdemir, and K. Bayazit Ten-Year Results With Liotta Porcine Bioprostheses in the Mitral Position Asian Cardiovasc Thorac Ann, December 1, 1998; 6(4): 260 - 264. [Abstract] [Full Text] [PDF]

				P. S. U. Myken, Håk. E. Berggren, S. Larsson, B. Roberts, I. Wallentin, and K. Caidahl LONG-TERM DOPPLER ECHOCARDIOGRAPHIC RESULTS OF AORTIC OR MITRAL VALVE REPLACEMENT WITH BIOCOR PORCINE BIOPROSTHESIS J. Thorac. Cardiovasc. Surg., October 1, 1998; 116(4): 599 - 608. [Abstract] [Full Text] [PDF]

				S. F. Katircioglu, B. Yamak, T. Ulus, L. Birincioglu, A. Saritas, O. Tasdemir, and K. Bayazit Mitral Valve Replacement with Bioprosthesis in Age Group Fifty to Sixty-Five Years Asian Cardiovasc Thorac Ann, March 1, 1998; 6(1): 23 - 27. [Abstract] [Full Text] [PDF]

				D. C. McGiffin, A. J. Galbraith, M. F. O'Brien, G. J. McLachlan, D. C. Naftel, P. Adams, S. Reddy, and L. Early AN ANALYSIS OF VALVE RE-REPLACEMENT AFTER AORTIC VALVE REPLACEMENT WITH BIOLOGIC DEVICES J. Thorac. Cardiovasc. Surg., February 1, 1997; 113(2): 311 - 318. [Abstract] [Full Text]

				A. Abolhoda, S. Yu, J. R. Oyarzun, K. R. Allen, J. R. McCormick, S. Han, F. W. Kemp, J. D. Bogden, Q. Lu, and S. Gabbay No-React Detoxification Process: A Superior Anticalcification Method for Bioprostheses Ann. Thorac. Surg., December 1, 1996; 62(6): 1724 - 1730. [Abstract] [Full Text]

				J. I. Fann, D. C. Miller, KathleenA. Moore, R. S. Mitchell, P. E. Oyer, E. B. Stinson, R. C. Robbins, B. A. Reitz, and N. E. Shumway Twenty-Year Clinical Experience With Porcine Bioprostheses Ann. Thorac. Surg., November 1, 1996; 62(5): 1301 - 1311. [Abstract] [Full Text]

				J. Dunmore-Buyze, D. R. Boughner, N. Macris, and I. Vesely A COMPARISON OF MACROSCOPIC LIPID CONTENT WITHIN PORCINE PULMONARY AND AORTIC VALVES: Implications for bioprosthetic valves J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1756 - 1761. [Abstract] [Full Text]

				D. M. Cosgrove, B. W. Lytle, P. C. Taylor, M. T. Camacho, R. W. Stewart, P. M. McCarthy, D. P. Miller, M. R. Piedmonte, and F. D. Loop The Carpentier-Edwards pericardial aortic valve: Ten-year results J. Thorac. Cardiovasc. Surg., September 1, 1995; 110(3): 651 - 662. [Abstract] [Full Text]

				J. F. Nistal, A. Hurle, J. A. Gutierrez, F. Mazorra, J. M. Revuelta, and w. t. t. a. o. M. Fernandez Commissural dehiscence of Carpentier-Edwards mitral bioprostheses: Explant analysis and pathogenesis J. Thorac. Cardiovasc. Surg., September 1, 1995; 110(3): 688 - 696. [Abstract] [Full Text]

				D. D. Glower, W. D. White, A. C. Hatton, L. R. Smith, W. G. Young, W. G. Wolfe, and J. E. Lowe Determinants of reoperation after 960 valve replacements with Carpentier-Edwards prostheses J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 381 - 393. [Abstract] [Full Text]

				K. E. Hammermeister, G. K. Sethi, W. G. Henderson, C. Oprian, T. Kim, S. Rahimtoola, and The Veterans Affairs Cooperative Study on Valvular A Comparison of Outcomes in Men 11 Years after Heart-Valve Replacement with a Mechanical Valve or Bioprosthesis N. Engl. J. Med., May 6, 1993; 328(18): 1289 - 1296. [Abstract] [Full Text]

				M. Alam and H. S. Rosman Echocardiographic and Color Flow Doppler Features of Bioprosthetic Valve Degeneration Vascular and Endovascular Surgery, January 1, 1991; 25(1): 60 - 63. [Abstract] [PDF]